-
Asian stocks tumble as Trump gives Iran 48-hour ultimatum
-
Wolves rally past Celtics, Nuggets sink Blazers
-
Middle East war to dominate Houston's 'Davos of Energy'
-
Kim holds off Korda charge to win LPGA Founders Cup
-
Trump orders immigration agents to airports amid crippling budget standoff
-
Iran awaits Trump threat to blow up power plants
-
Alcaraz eyes clay court season after early Miami exit
-
Real Madrid down Atletico in derby, leaders Barca edge Rayo
-
Korda sends Alcaraz to another early exit in Miami
-
Bordeaux-Begles hammer Toulouse in Dupont absence
-
Slovenia PM claims election win as results show neck and neck finish
-
England's Fitzpatrick birdies 18th to win PGA Valspar title
-
Man City's League Cup glory adds twist to title race
-
Leftists win mayoral elections in Paris and Marseille
-
Vinicius double helps Real Madrid edge Atletico thriller
-
Doncic cleared to face Pistons after foul rescinded: NBA
-
Inter's Serie A lead cut to six with Fiorentina draw, Como march on
-
World No.1 Alcaraz beaten by Korda in Miami Open third round
-
Cuba starts to restore power after new blackout
-
Ovechkin nets 1,000th combined NHL season-playoffs goal
-
Undav doubles up as Stuttgart down Augsburg to go third
-
Leftists win mayoral elections in Paris and Marseille: projections
-
Israel warns weeks of fighting ahead in Mideast war
-
Guardiola revels in Man City's 'special' League Cup win over Arsenal
-
Hodgkinson headlines Britain's 'Super Sunday' at world indoors
-
Messi scores for Miami in 3-2 MLS victory at NYCFC
-
Bezzecchi wins second race of the season at Brazil MotoGP
-
Britain's Hodgkinson wins world indoor 800m gold
-
Former France and West Ham star Payet announces retirement
-
Man City's O'Reilly savours 'unbelievable' double in League Cup final win
-
Israel to advance ground operations in Lebanon after striking key bridge
-
Man City win League Cup as O'Reilly sinks Arsenal after Kepa blunder
-
Marseille downed by Lille in Ligue 1 as Lyon's struggles continue
-
NBA bans Mitchell, Champagnie one game for sparking melee
-
'Project Hail Mary' rockets to top of N. America box office
-
Syrians protest alcohol sale limits, curbs on personal freedom
-
Spurs can '100 percent' avoid nightmare of relegation: Saltor
-
Araujo header scrapes Liga leaders Barcelona win over Rayo
-
Israel launches strikes as Lebanon warns of invasion
-
Torrential rains in Kenya kill 81 in March: officials
-
Iran threatens Mideast infrastructure after Trump ultimatum
-
Spurs felled by Forest in relegation battle, Sunderland shock Newcastle
-
Spurs collapse against Forest, failing acid test
-
US may 'escalate to de-escalate' against Iran: Treasury chief
-
Howe disappointed in himself after 'painful' Newcastle defeat
-
Quansah to miss England's pre-World Cup friendlies
-
Araujo header scrapes Liga leaders Barca win over Rayo
-
Georgia buries Patriarch Ilia II as succession stirs fears of Russian influence
-
DeChambeau wins back-to-back LIV Golf play-offs
-
Sunderland inflict more derby pain on Newcastle
Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care
Peer-reviewed study finds Flo Health's Symptom Checker could deliver nearly $10,100 in net monetary benefit per patient while cutting diagnosis wait time in half
NEW YORK CITY, NY / ACCESS Newswire / March 3, 2026 / Flo Health, the world's #1 women's health app, today announced publication of the first-ever economic evaluation of a digital symptom checker for endometriosis, underscoring the significant financial and health benefits that digital health technology can deliver to women navigating one of the most under-recognized conditions in gynecologic care.
The study, titled "Economic evaluation of a digital symptom checker for endometriosis using a Markov decision process model," and published in npj Digital Medicine, a top peer-reviewed journal in the Nature Portfolio, was conducted in partnership with researchers from The London School of Hygiene & Tropical Medicine and the York Health Economic Consortium. It examined the health and economic outcomes of using Flo Health's Symptom Checker alongside standard care, compared to standard care alone.
Despite affecting approximately 190 million women globally, endometriosis carries an average diagnostic delay of seven years, during which women frequently experience severe menstrual cramps, chronic pelvic pain, and pain during intercourse while receiving insufficient guidance. This delay is associated with increased disease severity, worsening pain, and more complex treatment paths.
The research produced the following key findings:
Women using Flo Health's Symptom Checker alongside standard care received diagnoses in approximately 3 years, compared to the 7-year average under standard care alone, a reduction of more than 50%
Patients gained nearly three weeks of additional healthy life, as measured by quality-adjusted life years (QALYs)
The tool generated approximately $5,196 USD in savings per person over 40 years through reduced medical costs and productivity gains
The total net monetary benefit per patient reached $10,089 USD, based on a willingness-to-pay threshold of $100,000 per QALY, a common benchmark for U.S. institutional payers
"When women are empowered to take control of their health, the benefits go beyond early diagnoses to overall improved physical and emotional well-being," said Dr. Anna Klepchukova, Chief Medical Officer at Flo Health. "This research explores how digital tools may help women better recognize their symptoms and bring clearer insights into conversations with their health care providers."
Flo Health's Symptom Checker is designed as an educational resource that helps users identify symptom patterns that may be consistent with endometriosis, prompting earlier engagement with health care providers. The tool is not intended to diagnose, treat, or replace professional medical care. More than 2.7 million women in the United States have used Flo Health's Symptom Tracker for endometriosis-related support.
Researchers also noted that digital symptom checkers provide the greatest value when tool accuracy exceeds 70%, user compliance surpasses 45%, and outcomes are measured over a minimum 10-year time horizon. The authors indicate that the economic modeling framework applied in this study could be replicated to evaluate digital health tools targeting other conditions that disproportionately affect women and face similar barriers to timely diagnosis.
The publication adds to a growing body of evidence supporting Flo Health's mission to build a better future for female health through trusted, data-backed digital tools. Flo Health currently supports 77 million monthly active users and collaborates with more than 100 medical experts worldwide.
About Flo Health
Flo Health is the leading app in the Health & Fitness category and the #1 OB-GYN-recommended app for period and cycle tracking. As the first European femtech unicorn following a General Atlantic investment in July 2024, Flo Health supports 77 million monthly active users with curated cycle and ovulation tracking, tailored health insights, and a private community for women at every stage of life. Through its Pass it on Project, Flo Health has donated 20 million Premium subscriptions toward its goal of providing 1 billion women in need with free access to health information. For more information, visit flo.health.
PR Contact
Samantha Wannemacher
Flo Health
[email protected]
SOURCE: Flo Health
View the original press release on ACCESS Newswire
E.Rodriguez--AT